Evaluation of neuronal protective effects of xanthine oxidoreductase inhibitors on severe whole-brain ischemia in mouse model and analysis of xanthine oxidoreductase activity in the mouse brain

Neurologia Medico-chirurgica
Go SuzukiHiroyuki Yokota

Abstract

Global cerebral ischemia and reperfusion (I/R) often result in high mortality. Free radicals play an important role in global cerebral I/R. Xanthine oxidoreductase (XOR) inhibitors, such as allopurinol, have been reported to protect tissues from damage caused by reactive oxygen species (ROS) by inhibiting its production through XOR inhibition. The recently introduced XOR inhibitor febuxostat, which is a more potent inhibitor than allopurinol, is expected to decrease free radical production more effectively. Here, we analyzed the effects of allopurinol and febuxostat in decreasing global severe cerebral I/R damage in mice. Mice were divided into three groups: a placebo group, an allopurinol group, and a febuxostat group. Pathological examinations, which were performed in each group in the CA1 and CA2 regions of the hippocampus 4 days after I/R surgery, revealed that there was a decrease in the number of neuronal cells in the 14-min occlusion model in both regions and that drugs that were administered to prevent this damage were not effective. The enzymatic activity was extremely low in the mouse brain, and XOR could not be detected in the nonischemic and ischemic mice brains with western blot analyses. Thus, one of the reasons f...Continue Reading

References

May 1, 1979·Stroke; a Journal of Cerebral Circulation·W A Pulsinelli, J B Brierley
Dec 1, 1991·The American Journal of Physiology·S LindsayJ S Beckman
Feb 1, 1991·The American Journal of Physiology·A L BetzD Martz
Jan 1, 1989·Advances in Experimental Medicine and Biology·Y HattoriA Ichikawa
Jan 17, 1985·The New England Journal of Medicine·J M McCord
Nov 1, 1986·Stroke; a Journal of Cerebral Circulation·T ItohM Nakamura
May 1, 1985·Stroke; a Journal of Cerebral Circulation·M KameyamaA Ogawa
Sep 14, 1993·European Journal of Pharmacology·Y OsadaK Komoriya
Apr 16, 1998·Neurologia Medico-chirurgica·R L Macdonald, M Stoodley
Oct 31, 2000·Journal of the Neurological Sciences·B C WhiteG S Krause
Jan 30, 2004·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ichiro YonekuraTakaaki Kirino
Apr 15, 2004·Journal of Neurology·Tobias BackOlaf G Schüler
Aug 10, 2004·The Journal of Experimental Biology·David S WarnerInes Batinić-Haberle
Nov 1, 2005·Surgical Neurology·Nejat IşikAydin Sav
Dec 13, 2005·The New England Journal of Medicine·Michael A BeckerNancy Joseph-Ridge
Dec 8, 2006·Nature·Ed S LeinAllan R Jones
Aug 7, 2010·Journal of Neuroscience Methods·Serge C ThalNikolaus Plesnila

❮ Previous
Next ❯

Methods Mentioned

BETA
Protein Assay
electrophoresis

Software Mentioned

Image [UNK] SVP
SigmaStat

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.